CrossrefInfokarte
Efficacy of switching to brolucizumab for neovascular age-related macular degeneration refractory to faricimab
Japanese Journal of Ophthalmology · 2025-03 · 69 (2) · 221-229
DOI: 10.1007/s10384-024-01146-3 ↗Abstract
Kein Abstract verfügbar.
EUVIMED